| 发明名称 |
CYTOTHERAPEUTICS, CYTOTHERAPEUTIC UNIT AND METHOD FOR TREATMENT USING THEM |
| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide improved cytotherapeutic formulations regarding the improvement of therapeutics utilizing cytotherapeutic formulations, a method for producing them, unit dosage forms of such agents and new paradigms administering cytotherapeutic units to patients in need of therapy. <P>SOLUTION: The present invention provides cytotherapeutic units comprising predetermined numbers of selected types of cells having differentiation potency. Assurance of the nature and identities of such cells is achieved through assay and certification of the numbers and identities. Therapeutic modalities are provided. Libraries of cell preparations with assayed and preferably certified populations are preferred and the preparation of cell preparations tailored to specific patients or disease states are provided. <P>COPYRIGHT: (C)2012,JPO&INPIT |
| 申请公布号 |
JP2011225606(A) |
申请公布日期 |
2011.11.10 |
| 申请号 |
JP20110160949 |
申请日期 |
2011.07.22 |
| 申请人 |
ANTHROGENESIS CORP |
发明人 |
HARIRI ROBERT J |
| 分类号 |
A61K35/12;A01N63/00;A61K35/14;A61K35/44;A61K35/50;A61K48/00;A61P1/16;A61P3/00;A61P7/00;A61P7/06;A61P11/00;A61P13/00;A61P15/14;A61P17/14;A61P19/00;A61P19/10;A61P25/00;A61P25/16;A61P25/28;A61P27/02;A61P35/00;A61P35/02;A61P37/00;C12N5/00;C12N5/073;C12N5/0735;C12N5/0789;C12N5/08;C12N15/63;C40B40/02 |
主分类号 |
A61K35/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
